A citation-based method for searching scientific literature

Sebastian Bauer, Suzanne George, Margaret von Mehren, Michael C Heinrich. Front Oncol 2021
Times Cited: 2







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



ALK and NRG1 Fusions Coexist in a Patient with Signet Ring Cell Lung Adenocarcinoma.
Lucia Anna Muscarella, Domenico Trombetta, Federico Pio Fabrizio, Aldo Scarpa, Vito Michele Fazio, Evaristo Maiello, Antonio Rossi, Paolo Graziano. J Thorac Oncol 2017
14
50

NRG1-ErbB Lost in Translation: A New Paradigm for Lung Cancer?
Domenico Trombetta, Antonio Rossi, Federico P Fabrizio, A Sparaneo, Paolo Graziano, Vito M Fazio, Lucia A Muscarella. Curr Med Chem 2017
13
50

Successful targeting of the NRG1 pathway indicates novel treatment strategy for metastatic cancer.
M R Jones, H Lim, Y Shen, E Pleasance, C Ch'ng, C Reisle, S Leelakumari, C Zhao, S Yip, J Ho,[...]. Ann Oncol 2017
54
50

Therapeutic Potential of Afatinib in NRG1 Fusion-Driven Solid Tumors: A Case Series.
Jacques Cadranel, Stephen V Liu, Michaël Duruisseaux, Eva Branden, Yasushi Goto, Benjamin A Weinberg, Christoph Heining, Richard F Schlenk, Parneet Cheema, Martin R Jones,[...]. Oncologist 2021
11
50

Durable Response to Afatinib in Lung Adenocarcinoma Harboring NRG1 Gene Fusions.
Nathan D Gay, Ying Wang, Carol Beadling, Andrea Warrick, Tanaya Neff, Christopher L Corless, Khaled Tolba. J Thorac Oncol 2017
39
50

Neuregulins and cancer.
Juan Carlos Montero, Ruth Rodríguez-Barrueco, Alberto Ocaña, Elena Díaz-Rodríguez, Azucena Esparís-Ogando, Atanasio Pandiella. Clin Cancer Res 2008
73
50

Neuregulin growth factors and their ErbB receptors form a potential signaling network for schwannoma tumorigenesis.
Mark S Stonecypher, Abhik Ray Chaudhury, Stephanie J Byer, Steven L Carroll. J Neuropathol Exp Neurol 2006
41
50


Neuregulin 1 expression is a predictive biomarker for response to AV-203, an ERBB3 inhibitory antibody, in human tumor models.
Kristan Meetze, Sylvie Vincent, Steven Tyler, Elizabeth K Mazsa, Andrea R Delpero, Steve Bottega, Donna McIntosh, Richard Nicoletti, William M Winston, Solly Weiler,[...]. Clin Cancer Res 2015
36
50

Novel Preclinical Patient-Derived Lung Cancer Models Reveal Inhibition of HER3 and MTOR Signaling as Therapeutic Strategies for NRG1 Fusion-Positive Cancers.
Igor Odintsov, Marissa S Mattar, Allan J W Lui, Michael Offin, Christopher Kurzatkowski, Lukas Delasos, Inna Khodos, Marina Asher, Robert M Daly, Natasha Rekhtman,[...]. J Thorac Oncol 2021
3
50

Loss of H3K27me3 Expression Is a Highly Sensitive Marker for Sporadic and Radiation-induced MPNST.
Carlos N Prieto-Granada, Thomas Wiesner, Jane L Messina, Achim A Jungbluth, Ping Chi, Cristina R Antonescu. Am J Surg Pathol 2016
132
50

Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma Network.
G D Demetri, C R Antonescu, B Bjerkehagen, J V M G Bovée, K Boye, M Chacón, A P Dei Tos, J Desai, J A Fletcher, H Gelderblom,[...]. Ann Oncol 2020
28
50

Denosumab in advanced/unresectable giant-cell tumour of bone (GCTB): For how long?
E Palmerini, N S Chawla, S Ferrari, M Sudan, P Picci, E Marchesi, M Piccinni Leopardi, I Syed, K K Sankhala, P Parthasarathy,[...]. Eur J Cancer 2017
61
50


Oncogenic function and clinical implications of SLC3A2-NRG1 fusion in invasive mucinous adenocarcinoma of the lung.
Dong Hoon Shin, Donghoon Lee, Dong Wan Hong, Seung Hyun Hong, Jung-Ah Hwang, Byung Il Lee, Hye Jin You, Geon Kook Lee, In-Hoo Kim, Yeon-Su Lee,[...]. Oncotarget 2016
40
50

Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor.
James E Butrynski, David R D'Adamo, Jason L Hornick, Paola Dal Cin, Cristina R Antonescu, Suresh C Jhanwar, Marc Ladanyi, Marzia Capelletti, Scott J Rodig, Nikhil Ramaiya,[...]. N Engl J Med 2010
520
50

NRG1 Gene Fusions Are Recurrent, Clinically Actionable Gene Rearrangements in KRAS Wild-Type Pancreatic Ductal Adenocarcinoma.
Martin R Jones, Laura M Williamson, James T Topham, Michael K C Lee, Angela Goytain, Julie Ho, Robert E Denroche, GunHo Jang, Erin Pleasance, Yaoquing Shen,[...]. Clin Cancer Res 2019
45
50

NRG1 fusion-driven tumors: biology, detection, and the therapeutic role of afatinib and other ErbB-targeting agents.
J Laskin, S V Liu, K Tolba, C Heining, R F Schlenk, P Cheema, J Cadranel, M R Jones, A Drilon, A Cseh,[...]. Ann Oncol 2020
17
50

NRG1 Fusions in KRAS Wild-Type Pancreatic Cancer.
Christoph Heining, Peter Horak, Sebastian Uhrig, Paula L Codo, Barbara Klink, Barbara Hutter, Martina Fröhlich, David Bonekamp, Daniela Richter, Katja Steiger,[...]. Cancer Discov 2018
83
50

Molecular Pathways: Targeting NRG1 Fusions in Lung Cancer.
Lynnette Fernandez-Cuesta, Roman K Thomas. Clin Cancer Res 2015
41
50

14-3-3 fusion oncogenes in high-grade endometrial stromal sarcoma.
Cheng-Han Lee, Wen-Bin Ou, Adrian Mariño-Enriquez, Meijun Zhu, Mark Mayeda, Yuexiang Wang, Xiangqian Guo, Alayne L Brunner, Frédéric Amant, Christopher A French,[...]. Proc Natl Acad Sci U S A 2012
155
50

Fusion of the ZC3H7B and BCOR genes in endometrial stromal sarcomas carrying an X;22-translocation.
Ioannis Panagopoulos, Jim Thorsen, Ludmila Gorunova, Lisbeth Haugom, Bodil Bjerkehagen, Ben Davidson, Sverre Heim, Francesca Micci. Genes Chromosomes Cancer 2013
81
50

The Anti-HER3 mAb Seribantumab Effectively Inhibits Growth of Patient-Derived and Isogenic Cell Line and Xenograft Models with Oncogenic NRG1 Fusions.
Igor Odintsov, Allan J W Lui, Whitney J Sisso, Eric Gladstone, Zebing Liu, Lukas Delasos, Renate I Kurth, Exequiel M Sisso, Morana Vojnic, Inna Khodos,[...]. Clin Cancer Res 2021
3
50

Constitutive activation of neuregulin/ERBB3 signaling pathway in clear cell sarcoma of soft tissue.
Karl-Ludwig Schaefer, Kristin Brachwitz, Yvonne Braun, Raihanatou Diallo, Daniel H Wai, Susanne Zahn, Dominik T Schneider, Cornelius Kuhnen, Arabel Vollmann, Gero Brockhoff,[...]. Neoplasia 2006
20
50

Diagnosis of known sarcoma fusions and novel fusion partners by targeted RNA sequencing with identification of a recurrent ACTB-FOSB fusion in pseudomyogenic hemangioendothelioma.
Guo Zhu, Ryma Benayed, Caleb Ho, Kerry Mullaney, Purvil Sukhadia, Kelly Rios, Ryan Berry, Brian P Rubin, Khedoudja Nafa, Lu Wang,[...]. Mod Pathol 2019
56
50

Detection of NRG1 Gene Fusions in Solid Tumors.
Sushma Jonna, Rebecca A Feldman, Jeffrey Swensen, Zoran Gatalica, Wolfgang M Korn, Hossein Borghaei, Patrick C Ma, Jorge J Nieva, Alexander I Spira, Ari M Vanderwalde,[...]. Clin Cancer Res 2019
70
50

Frequency of known gene rearrangements in endometrial stromal tumors.
Sarah Chiang, Rola Ali, Nataliya Melnyk, Jessica N McAlpine, David G Huntsman, C Blake Gilks, Cheng-Han Lee, Esther Oliva. Am J Surg Pathol 2011
74
50

BCOR Internal Tandem Duplication in High-grade Uterine Sarcomas.
Adrián Mariño-Enriquez, Alexandra Lauria, Joanna Przybyl, Tony L Ng, Magdalena Kowalewska, Maria Debiec-Rychter, Raji Ganesan, Vaiyapuri Sumathi, Suzanne George, W Glenn McCluggage,[...]. Am J Surg Pathol 2018
54
50

Histopathologic evaluation of atypical neurofibromatous tumors and their transformation into malignant peripheral nerve sheath tumor in patients with neurofibromatosis 1-a consensus overview.
Markku M Miettinen, Cristina R Antonescu, Christopher D M Fletcher, Aerang Kim, Alexander J Lazar, Martha M Quezado, Karlyne M Reilly, Anat Stemmer-Rachamimov, Douglas R Stewart, David Viskochil,[...]. Hum Pathol 2017
120
50

Comparing children and adults with synovial sarcoma in the Surveillance, Epidemiology, and End Results program, 1983 to 2005: an analysis of 1268 patients.
Iyad Sultan, Carlos Rodriguez-Galindo, Raya Saab, Sameer Yasir, Michela Casanova, Andrea Ferrari. Cancer 2009
163
50

Response to ERBB3-Directed Targeted Therapy in NRG1-Rearranged Cancers.
Alexander Drilon, Romel Somwar, Biju P Mangatt, Henrik Edgren, Patrice Desmeules, Anja Ruusulehto, Roger S Smith, Lukas Delasos, Morana Vojnic, Andrew J Plodkowski,[...]. Cancer Discov 2018
83
50

Comparison of the inhibitory effects of azole antifungals on cytochrome P450 3A4 genetic variants.
Yuki Yamaguchi, Takeshi Akiyoshi, Go Kawamura, Ayuko Imaoka, Mitsue Miyazaki, F Peter Guengerich, Katsunori Nakamura, Koujirou Yamamoto, Hisakazu Ohtani. Drug Metab Pharmacokinet 2021
2
50


Treatment of invasive fungal infections in cancer patients-updated recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).
Sabine Mousset, Dieter Buchheidt, Werner Heinz, Markus Ruhnke, Oliver A Cornely, Gerlinde Egerer, William Krüger, Hartmut Link, Silke Neumann, Helmut Ostermann,[...]. Ann Hematol 2014
77
50



Ripretinib in gastrointestinal stromal tumor: the long-awaited step forward.
M Julia Lostes-Bardaji, David García-Illescas, Claudia Valverde, César Serrano. Ther Adv Med Oncol 2021
3
50

UPLC-MS/MS Measurement of the Effect of Isavuconazole, Itraconazole and Fluconazole on the Pharmacokinetics of Selinexor in Rats.
Shuang-Long Li, Yi Zhang, Qian-Shi Cheng, Jun-Zhe Xin, Ze-Qin Dong, Xiang-Jun Qiu. Infect Drug Resist 2020
5
50

Revolutions in treatment options in gastrointestinal stromal tumours (GISTs): the latest updates
Sheima Farag, Myles J Smith, Nicos Fotiadis, Anastasia Constantinidou, Robin L Jones. Curr Treat Options Oncol 2020
14
50

Simultaneous Determination of Celecoxib, Dezocine and Dexmedetomidine in Beagle Plasma Using UPLC-MS/MS Method and the Application in Pharmacokinetics.
Jie Hu, Xin-Juan Su, Hui-Ling Si, Rui-Xiang Song, Fang Zhang, Xiang-Jun Qiu, Xing-Peng Chen. Drug Des Devel Ther 2021
2
50


Switch Control Inhibition of KIT and PDGFRA in Patients With Advanced Gastrointestinal Stromal Tumor: A Phase I Study of Ripretinib.
Filip Janku, Albiruni R Abdul Razak, Ping Chi, Michael C Heinrich, Margaret von Mehren, Robin L Jones, Kristen Ganjoo, Jonathan Trent, Hans Gelderblom, Neeta Somaiah,[...]. J Clin Oncol 2020
22
50

Ripretinib (DCC-2618) Is a Switch Control Kinase Inhibitor of a Broad Spectrum of Oncogenic and Drug-Resistant KIT and PDGFRA Variants.
Bryan D Smith, Michael D Kaufman, Wei-Ping Lu, Anu Gupta, Cynthia B Leary, Scott C Wise, Thomas J Rutkoski, Yu Mi Ahn, Gada Al-Ani, Stacie L Bulfer,[...]. Cancer Cell 2019
71
50


Establishment and Verification of UPLC-MS/MS Technique for Pharmacokinetic Drug-Drug Interactions of Selinexor with Posaconazole in Rats.
Chen-Jian Zhou, Hui-Jun Wang, Chun-Yan Zhou, Chao-Fan Li, Ming-Jia Zhu, Xiang-Jun Qiu. Drug Des Devel Ther 2021
4
50

Gastrointestinal Stromal Tumors (GISTs): Novel Therapeutic Strategies with Immunotherapy and Small Molecules.
Christos Vallilas, Panagiotis Sarantis, Anastasios Kyriazoglou, Evangelos Koustas, Stamatios Theocharis, Athanasios G Papavassiliou, Michalis V Karamouzis. Int J Mol Sci 2021
4
50

Ripretinib: First Approval.
Sohita Dhillon. Drugs 2020
14
50

The Influence of Different Triazole Antifungal Agents on the Pharmacokinetics of Cyclophosphamide.
Tian Cai, Youming Liao, Zhenhua Chen, Yingchang Zhu, Xincai Qiu. Ann Pharmacother 2020
2
50



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.